PATENT CLAIM ANALYSIS

Application Number: 16123072
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["544", "310000"]

Abstract:
The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), and Parkinson's disease.

Claim (Index 4):
The method of  claim 3  wherein:\n R 10  is selected from the group consisting of \u2014CN, C 1-4  alkyl, C 3-4  cycloalkyl, cyclopropylmethyl, and cyclobutylmethyl, wherein the C 1-4  alkyl of R 10  is optionally substituted with 1, 2, 3, or 4 substituents each independently selected from the group consisting of halogen, \u2014OH, \u2014CN, C 1-4  alkoxy, and C 1-4  haloalkoxy; and wherein each of the C 3-4  cycloalkyl, cyclopropylmethyl, and cyclobutylmethyl of R 10  is optionally substituted with 1, 2, 3, or 4 substituents each independently selected from the group consisting of halogen, \u2014OH, \u2014CN, C 1-4  alkyl, C 1-4  haloalkyl, C 1-4  hydroxylalkyl, C 1-4  alkoxy, and C 1-4  haloalkoxy; \n R 10A  is selected from the group consisting of H, C 1-3  alkyl, C 1-3  hydroxylalkyl, C 2-4  alkenyl, \u2014S(\u2550O) 2 N(R 5 )(R 6 ), \u2014C(\u2550O)\u2014N(R 5 )(R 6 ), \u2014C(\u2550O)\u2014R 8 , \u2014C(\u2550O)\u2014OR 8 , \u2014C(R 14 ) 2 \u2014OH, \u2014C(R 14 ) 2 \u2014OS(\u2550O) 2 H, \u2014C(R 14 ) 2 \u2014OP(\u2550O)(OH) 2 , \u2014C(R 14 ) 2 \u2014OR 15 , and \u2014C(R 14 ) 2 \u2014OC(\u2550O)\u2014R 15 ; and \n R 10B  is selected from the group consisting of C 1-4  alkyl, C 3-4  cycloalkyl, cyclopropylmethyl, and cyclobutylmethyl, wherein the C 1-4  alkyl of R 10B  is optionally substituted with 1, 2, 3, or 4 substituents each independently selected from the group consisting of halogen, \u2014OH, \u2014CN, C 1-4  alkoxy, and C 1-4  haloalkoxy; and wherein each of the C 3-4  cycloalkyl, cyclopropylmethyl, and cyclobutylmethyl of R 10B  is optionally substituted with 1, 2, 3, or 4 substituents each independently selected from the group consisting of halogen, \u2014OH, \u2014CN, C 1-4  alkyl, C 1-4  haloalkyl, C 1-4  hydroxylalkyl, C 1-4  alkoxy, and C 1-4  haloalkoxy.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.68519
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14311963', '15729111', '15349075', '14819541', '14339123']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8252604187596035
- 35 USC 102 Novelty (BERT): 0.5831653767881959
- Combined Prediction Score: 0.8010509145624628
- Mean Citation Score: 447.258236
- Max Citation Score: 471.30627
- Similarity Product: 468.0054830626005

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test